778
T.-S. Jang et al.
SPECIAL TOPIC
impact mass spectra (EIMS) were recorded in the form of m/z on an
Agilent GC-MSD (6850-5973) system. Flash column chromatogra-
phy was performed on silica gel 60 (E. Merck).
1-(4-tert-Butylphenyl)-3-buten-1-ol (3g)
1H NMR (CDCl3): = 7.26–7.38 (4 H, m), 5.75–5.88 (1 H, m),
5.11–5.19 (2 H, m), 4.69 (1 H, t, J = 6.5 Hz), 2.48–2.52 (2 H, m),
2.06 (1 H, br), 1.31 (9 H, s).
Alcohols; General Procedure
13C NMR (CDCl3): = 150.43, 140.86, 134.69, 125.52, 125.27,
118.12, 73.11, 43.58, 34.46, 31.32.
MS (EI, 70 eV): m/z (%) = 186 [M+ – 18], 163 (100), 148, 133, 91,
A mixture of aldehyde (0.5 mmol), allyl alcohol (1.5 mmol), indium
(1.0 mmol), indium(III) chloride (0.25 mmol) and Pd(PPh3)4 (2
mol%) in THF–H2O, 1:1, 1 ml was stirred for 20 h at r.t. The reac-
tion was quenched with 1N HCl (1 mL), EtOAc (1 mL), and the
whole mixture was filtered through celite. After general work-up,
purification by flash column chromatography on silica gel (hexane–
EtOAc, 10:1) afforded the product.
77, 57.
1-(4-Methoxyphenyl)-3-buten-1-ol (3h)
1H NMR (CDCl3): = 7.23–7.27 (2 H, m), 6.84–6.88 (2 H, m),
5.70–5.84 (1 H, m), 5.08–5.16 (2 H, m), 4.64 (1 H, t, J = 6.5 Hz),
3.78 (3 H, s), 2.47 (2 H, m), 2.23 (1 H, br).
1-Phenyl-3-buten-1-ol (3a)
1H NMR (CDCl3): = 7.21–7.35 (5 H, m), 5.69–5.83 (1 H, m),
5.08–5.15 (2 H, m), 4.66 (1 H, t, J = 6.6 Hz), 2.44–2.49 (2 H, m),
2.35 (1 H, br).
13C NMR (CDCl3): = 158.66, 135.80, 133.80, 134.34, 126.77,
117.76, 113.44, 72.68, 54.93, 43.38.
MS (EI, 70 eV): m/z (%) = 160 (100) [M+ – 18], 144, 129, 115, 91,
13C NMR (CDCl3): = 143.81, 134.46, 128.26, 127.39, 125.74,
118.11, 73.23, 43.62.
77, 63.
MS (EI, 70 eV): m/z (%) = 148 [M+], 107 (100), 97, 77.
4-(1-Hydroxy-but-3-enyl)-benzonitrile (3i)
1H NMR (CDCl3): = 7.61–7.63 (2 H, m), 7.45–7.48 (2 H, m),
5.70–5.84 (1 H, m), 5.11–5.18 (2 H, m), 4.80 (1 H, dd, J = 7.7, 5.0
Hz), 2.41–2.57 (3 H, m).
1-(2-Fluorophenyl)-3-buten-1-ol (3b)
1H NMR (CDCl3): = 7.43–7.48 (1 H, m), 7.19–7.27 (1 H, m),
7.10–7.16 (1 H, m), 6.97–7.04 (1 H, m), 5.74–5.87 (1 H, m), 5.11–
5.18 (2 H, m), 5.04 (1 H, dd, J = 7.8, 5.1), 2.42–2.61 (2 H, m).
13C NMR (CDCl3): = 149.19, 133.29, 132.09, 119.19, 118.75,
110.91, 72.29, 43.66.
13C NMR (CDCl3): = 159.62, 134.07, 128.80, 128.69, 127.16,
124.13, 118.52, 115.22, 67.17, 42.48.
MS (EI, 70 eV) m/z (%) = 173 [M+], 132 (100), 104, 77.
MS (EI, 70 eV): m/z (%) = 166 [M+], 125(100), 97, 77.
Methyl 4-(1-Hydroxy-but-3-enyl)-benzoate (3j)
1H NMR (CDCl3): = 8.01 (2 H, m), 7.42 (2 H, d, J = 8.4 Hz),
5.72–5.83 (1 H, m), 5.13–5.19 (2 H, m), 4.80 (1 H, dd, J = 7.7, 5.1
Hz), 3.91 (3 H, s), 2.44–2.54 (2 H, m), 2.29 (1 H, br).
1-(3-Fluorophenyl)-3-buten-1-ol (3c)
1H NMR (CDCl3): = 7.26–7.31 (1 H, m), 7.06–7.11 (2 H, m),
6.93–6.96 (1 H, m), 5.13–5.19 (1 H, m), 5.13–5.18 (1 H, m), 4.72 (1
H, dd, J = 7.7, 5.1 Hz), 2.40–2.54 (2 H, m), 2.16 (1 H, br).
13C NMR (CDCl3): = 166.94, 148.96, 133.79, 129.69, 129.22,
118.91, 125.70, 72.73, 52.05, 43.77.
13C NMR (CDCl3): = 162.91, 146.52, 133.90, 129.84, 121.35,
118.81, 114.26, 112.71, 72.56, 43.74.
MS (EI, 70 eV): m/z (%) = 175 [M+ – 31], 165 (100), 133, 105, 91,
77, 59.
MS (EI, 70 eV): m/z (%) = 166 [M+], 125(100), 97, 77.
4-(1-Hydroxy-but-3-enyl)-benzoic acid (3k)
1H NMR (CD3OD): = 7.94 (2 H, m), 7.69 (2 H, d, J = 8.3 Hz),
5.70–5.79 (1 H, m), 4.95–5.02 (2 H, m), 4.70 (1 H, t, J = 6.5 Hz),
2.41–2.45 (2 H, m).
13C NMR (CD3OD): = 170.01, 151.10, 135.44, 130.72, 130.39,
127.01, 117.89, 74.23, 44.42.
1-(4-Fluorophenyl)-3-buten-1-ol (3d)
1H NMR (CDCl3): = 7.25–7.33 (2 H, m), 6.97–7.05 (2 H, m),
5.69–5.83 (1 H, m), 5.10–5.17 (2 H, m), 4.68 (1 H, t, J = 6.5 Hz),
2.43–2.48 (2 H, m), 2.32(1 H, br).
13C NMR (CDCl3): = 162.08, 139.53, 134.11, 127.41, 118.52,
115.12, 72.60, 43.82.
MS (EI, 70 eV): m/z (%) = 193 [M+ + 1], 175, 151 (100), 105, 79,
MS (EI, 70 eV): m/z (%) = 166 [M+], 125 (100), 97, 77.
77.
Tridec-1-en-4-ol (3l)
1-(2-Bromophenyl)-3-buten-1-ol (3e)
1H NMR (CDCl3): = 5.76–5.90 (1 H, m), 5.09–5.17 (2 H, m),
3.60–3.68 (1 H, m), 2.16–2.34 (1 H, m), 2.09–2.19 (1 H, m), 1.71 (1
H, br), 1.27–1.46 (16 H, m), 0.88 (3 H, t, J = 6.6 Hz).
1H NMR (CDCl3): = 7.48–7.54 (2 H, m), 7.28–7.34 (1 H, m),
7.08–7.13 (1 H, m), 5.79–5.93 (1 H, m), 5.14–5.20 (1 H, m), 5.08 (1
H, dd, J = 8.3, 3.8 Hz), 2.57–2.63 (1 H, m), 2.28–2.39 (2 H, m).
13C NMR (CDCl3): = 134.92, 117.95, 70.69, 36.81, 31.87, 29.63,
29.59, 29.54, 29.29, 25.64, 22.64, 14.06.
MS (EI, 70 eV): m/z (%) = 157 [M+ – 51], 97, 83 (100), 69, 55.
13C NMR (CDCl3): = 142.65, 134.18, 132.54, 128.71, 127.56,
127.26, 121.70, 118.52, 71.75, 41.97.
MS (EI, 70 eV): m/z (%) = 228 [M+ + 2], 226 [M+], 185 (100), 157,
77.
(E)-1-Phenyl-1,5-hexadien-3-ol (3m)
1H NMR (CDCl3): = 7.23–7.39 (5 H, m), 6.60 (1 H, d, J = 15.9
Hz), 6.23 (1 H, dd, J = 15.9, 6.3 Hz), 5.78–5.92 (1 H, m), 5.14–5.20
(2 H, m), 4.35 (1 H, q, J = 5.7 Hz), 2.32–2.48 (2 H, m).
13C NMR (CDCl3): = 136.62, 133.99, 131.50, 130.35, 128.53,
127.62, 126.44, 118.40, 71.71, 41.94.
MS (EI, 70 eV): m/z (%) = 156 [M+ – 18], 133 (100), 115, 105, 91,
77, 55.
1-(4-Methylphenyl)-3-buten-1-ol (3f)
1H NMR (CDCl3): = 7.12–7.23 (4 H, m), 5.71–5.85 (1 H, m),
5.09–5.16 (2 H, m), 4.66 (1 H, t, J = 6.5 Hz), 2.47 (2 H, m), 2.33 (3
H, s), 2.14 (1 H, br).
13C NMR (CDCl3): = 140.88, 137.08, 134.56, 129.00, 125.72,
118.06, 73.14, 43.64, 21.03.
MS (EI, 70 eV): m/z (%) = 144 [M+ – 18], 121 (100), 91, 77.
Synthesis 2003, No. 5, 775–779 ISSN 0039-7881 © Thieme Stuttgart · New York